eClinical Solutions Market Comprehensive Insights Of Recent Developments
According to ARC's latest market research report, the global eClinical Solutions Market is anticipated to generate revenues of around US$ 9,756 million by 2026, growing at a CAGR of over 9.7% during the forecast time frame 2019 to 2026.
The eclinical solutions refer to the development and offering of clinical technologies and expertise which are aimed at supporting the development of the clinical process. The eclinical solutions usually involve product solutions which include electronic data capture and clinical data management systems, clinical trial management systems, clinical analytics platforms, randomization, trial supply management, and clinical data integration platforms among others. The development of clinical trials and solutions has been a key component of the medical research industry ever since the outcomes of the very first clinical research were presented in the late 1950s. Clinical trials provide a base for fulfilling stringent drug approval processes which are made mandatory by the U.S. Food and Drug Administration (FDA). Clinical studies help in providing supportive research which is used to demonstrate the safety and efficiency of pharmaceutical drugs as well as medical devices. However, modern times have imparted more challenges for the pharmaceutical and medical device manufacturers, right from research & development to pricing and commercializing of products. Moreover, rising competition is forcing the industry players to innovate solutions that improve research & development efficiency while restoring profits.
Free Download Sample Report Pages for Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/1637
North America dominated the global eclinical solutions market in the year 2018. The region has experienced the potential growth owing to the presence of eclinical Solutions companies such as Oracle Corporation, Medidata Solutions, Inc. and Parexel International Corporation among others. The presence of a large pool of patients suffering from various diseases that are caused by changing lifestyles and high stress along with favorable policies implemented by various governments is further boosting the regional market growth. The North America region is expected to exhibit the largest share in the eclinical solutions market. The increasing number of investments in clinical trials in the region is expected to contribute to market growth. Additionally, according to a survey done in 2018 by the Tufts Center for the Study of Drug Development, an average of $2.6 billion is spent on new drug approvals which cover the cost of failures, and cost of research & develop which may take 10 to 15 years. Moreover, only one of every 10 drugs that initiate clinical trials is approved by the Food & Drug Safety Authority.
Electronic data capture and clinical data management systems in eclinical solutions have dominated the product segment in the year 2018 and the segment is projected to maintain its dominance over the forecast period from 2019 to 2026. Electronic data capture and clinical data management system is a computerized method of clinical data collection for human clinical trials. It is stored in an electronic format for further reporting and analysis of the collected information. In 2015, Dr. ASM Mosa conducted a study on Online Electronic Data Capture and Research Data for various user groups that include super users and primary users.
Phase I Clinical Trials segment dominated the eclinical solutions market on the basis of delivery mode in the year 2018. It is the most common type of clinical trials in medical and drug science. Phase I clinical trials involve a small number of human volunteers, usually less than 100, on whom the clinical trials are conducted in a small number of human volunteers in order to determine the safety and pharmacokinetics and pharmacodynamics of the drug. Parameters such as the relation between drug’s chemical properties and its effects on human bodies are determined through these trials.
Some of the leading competitors are Oracle Corporation, Medidata Solutions, Inc., Parexel International Corporation, Bioclinica, Inc. (A Subsidiary of Cinven), Datatrak International, Inc., CRF Health, ERT Clinical, Merge Healthcare Incorporated, Omnicomm Systems, Inc., Maxisit Inc., Bio-Optronics, Inc., and eClinical Solutions, LLC.
Some of the key observations regarding eclinical solutions industry include:
- In September 2019, Datatrak International, Inc., collaborated with NTT Data to expand their foothold in the Asia Pacific and Japan region
- Datatrak International, Inc. (OTC Markets: DTRK), showcased the Datatrak Enterprise Cloud at the 16th DIA Japan Annual Meeting in Tokyo, Japan in October 2019.
- August 2018, Datatrak International, Inc. raised USD 8 million from TabaFund for research in advancement of eclinical solutions.
- In December 2015, Boehringer Ingelheim partnered with Medidata Clinical Cloud to innovate drug development programs.
- In November 2015, Infinity Pharmaceuticals Inc. selected Medidata Clinical Cloud for research in oncology program.
- In February 2019, eClinical Solutions LLC, a leading provider for cloud based products for clinical research, initiated elluminate Validation Accelerator which helps life science companies in taking risk based approach to system validation.
Market Segment Analysis:
Acumen Research report focuses on market attractiveness by assessing the key market segments. The report also combines region-wise segments for a better understanding of the supply and demand ratio of this market. This exclusive study of the report analyzes the present and future market scenario and the industry trends that are influencing the growth of the segments. Besides, the report also covers the value chain analysis, supply chain analysis, and year-on-year basis analysis of this market.
Market Segmentation
Market by Product
- Electronic Data Capture and Clinical Data Management Systems
- Clinical Trial Management Systems
- Clinical Analytics Platforms
- Randomization and Trial Supply Management
- Clinical Data Integration Platforms
- Electronic Clinical Outcome Assessment Solutions
- Safety Solutions
- Electronic Trial Master File Systems
- Regulatory Information Management Solutions
- Others
Market by Delivery Mode
- Web-Hosted (On-Demand) Solutions
- Licensed Enterprise (On-Premise) Solutions
- Cloud-Based (SaaS) Solutions
Market by Clinical Trial Phase
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV Clinical Trials
Market by End-use
- Pharmaceutical and Biopharmaceutical Companies
- Contract Research Organizations
- Consulting Service Companies
- Medical Device Manufacturers
- Hospitals
- Academic Research Institutes
Market Regional Analysis:
Based on the regions, the global eClinical Solutions Market is segmented into -North America (US and Canada), Europe (UK, Germany, France, Spain and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of Asia-Pacific), Latin America (Mexico, Brazil and Rest of Latin America), Middle East & Africa (GCC, South Africa and Rest of MEA)
TABLE OF CONTENT
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of eClinical Solutions
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. eClinical Solutions Market By Product
1.2.2.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global eClinical Solutions Market Revenue Share By Product in 2018
1.2.2.3. Electronic Data Capture and Clinical Data Management Systems
1.2.2.4. Clinical Trial Management Systems
1.2.2.5. Clinical Analytics Platforms
1.2.2.6. Randomization and Trial Supply Management
1.2.2.7. Clinical Data Integration Platforms
1.2.2.8. Electronic Clinical Outcome Assessment Solutions
1.2.2.9. Safety Solutions
1.2.2.10. Electronic Trial Master File Systems
1.2.2.11. Regulatory Information Management Solutions
1.2.2.12. Others
1.2.3. eClinical Solutions Market By Delivery Mode
1.2.3.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By Delivery Mode (2015-2026)
1.2.3.2. Web-Hosted (On-Demand) Solutions
1.2.3.3. Licensed Enterprise (On-Premise) Solutions
1.2.3.4. Cloud-Based (SaaS) Solutions
1.2.4. eClinical Solutions Market By Clinical Trial Phase
1.2.4.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By Clinical Trial Phase (2015-2026)
1.2.4.2. Phase I Clinical Trials
1.2.4.3. Phase II Clinical Trials
1.2.4.4. Phase III Clinical Trials
1.2.4.5. Phase IV Clinical Trials
1.2.5. eClinical Solutions Market By End-use
1.2.5.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By End-user (2015-2026)
1.2.5.2. Pharmaceutical and Biopharmaceutical Companies
1.2.5.3. Contract Research Organizations
1.2.5.4. Consulting Service Companies
1.2.5.5. Medical Device Manufacturers
1.2.5.6. Hospitals
1.2.5.7. Academic Research Institutes
1.2.6. eClinical Solutions Market By Geography
1.2.6.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.6.2. North America eClinical Solutions Market Revenue and Growth Rate(2015-2026)
1.2.6.3. Europe eClinical Solutions Market Revenue and Growth Rate(2015-2026)
1.2.6.4. Asia-Pacific eClinical Solutions Market Revenue and Growth Rate(2015-2026)
1.2.6.5. Latin America eClinical Solutions Market Revenue and Growth Rate(2015-2026)
1.2.6.6. Middle East and Africa (MEA) eClinical Solutions Market Revenue and Growth Rate(2015-2026)
CHAPTER 2. MARKET DYNAMICSAND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global eClinical Solutions Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global eClinical Solutions Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global eClinical Solutions Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global eClinical Solutions Major Manufacturers in 2018
CHAPTER 4. ECLINICAL SOLUTIONS MARKET BY PRODUCT
4.1. Global eClinical Solutions Revenue By Product
4.2. Electronic Data Capture and Clinical Data Management Systems
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Clinical Trial Management Systems
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Clinical Analytics Platforms
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Randomization and Trial Supply Management
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Clinical Data Integration Platforms
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Electronic Clinical Outcome Assessment Solutions
4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.8. Safety Solutions
4.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.9. Electronic Trial Master File Systems
4.9.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.9.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.10. Regulatory Information Management Solutions
4.10.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.10.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.11. Others
4.11.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.11.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE
5.1. Global eClinical Solutions Revenue By Delivery Mode
5.2. Web-Hosted (On-Demand) Solutions
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Licensed Enterprise (On-Premise) Solutions
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Cloud-Based (SaaS) Solutions
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 6. ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE
6.1. Global eClinical Solutions Revenue By Clinical Trial Phase
6.2. Phase I Clinical Trials
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Phase II Clinical Trials
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Phase III Clinical Trials
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Phase IV Clinical Trials
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 7. ECLINICAL SOLUTIONS MARKET By End-use
7.1. Global eClinical Solutions Revenue By End-use
7.2. Pharmaceutical and Biopharmaceutical Companies
7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. Contract Research Organizations
7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Consulting Service Companies
7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.5. Medical Device Manufacturers
7.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.6. Hospitals
7.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.7. Academic Research Institutes
7.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 8. NORTH AMERICA ECLINICAL SOLUTIONS MARKET BY COUNTRY
8.1. North America eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. North America eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. U.S.
8.3.1. U.S. eClinical Solutions Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
8.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
8.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 9. EUROPE ECLINICAL SOLUTIONS MARKET BY COUNTRY
9.1. Europe eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Europe eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.6.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.7.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 10. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET BY COUNTRY
10.1. Asia-Pacific eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Asia-Pacific eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.6.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.6.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.6.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.7.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.7.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.7.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.8.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.8.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.8.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 11. LATIN AMERICA ECLINICAL SOLUTIONS MARKET BY COUNTRY
11.1. Latin America eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Latin America eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
11.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
11.4. Mexico
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
11.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
11.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 12. MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET BY COUNTRY
12.1. Middle East & Africa eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Middle East & Africa eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. GCC
12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
12.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
12.4. South Africa
12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
12.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
12.5. Rest of Middle East & Africa
12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
12.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 13. COMPANY PROFILE
13.1. Oracle Corporation
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Medidata Solutions, Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Parexel International Corporation
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Bioclinica, Inc. (A Subsidiary of Cinven)
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Datatrak International, Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. CRF Health
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. ERT Clinical
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Merge Healthcare Incorporated
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Omnicomm Systems, Inc.
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Maxisit Inc.
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Bio-Optronics, Inc.
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies
13.12. Others
13.12.1. Company Snapshot
13.12.2. Overview
13.12.3. Financial Overview
13.12.4. Type Portfolio
13.12.5. Key Developments
13.12.6. Strategies
CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope
Contact Here, sales@acumenresearchandconsulting.com | +1 407 915 4157 OR +1 408 900 9135
The report is readily available and can be dispatched immediately after payment confirmation.
Buy this premium research report@ https://www.acumenresearchandconsulting.com/buy-now/0/1637
About Acumen Research and Consulting:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.